Culp-Hill, R.; Nichols, C.M.; Kilkenny, S.; Goldberg, M.; Radnaa, E.; Wong, M.; Zapata, M.; Behbakht, K.; Bitler, B.G.; Jeter, A.;
et al. Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum. Diagnostics 2026, 16, 2143.
https://doi.org/10.3390/diagnostics16142143
AMA Style
Culp-Hill R, Nichols CM, Kilkenny S, Goldberg M, Radnaa E, Wong M, Zapata M, Behbakht K, Bitler BG, Jeter A,
et al. Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum. Diagnostics. 2026; 16(14):2143.
https://doi.org/10.3390/diagnostics16142143
Chicago/Turabian Style
Culp-Hill, Rachel, Charles M. Nichols, Shannon Kilkenny, Mattie Goldberg, Enkhtuya Radnaa, Maria Wong, Moisés Zapata, Kian Behbakht, Benjamin G. Bitler, Anna Jeter,
and et al. 2026. "Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum" Diagnostics 16, no. 14: 2143.
https://doi.org/10.3390/diagnostics16142143
APA Style
Culp-Hill, R., Nichols, C. M., Kilkenny, S., Goldberg, M., Radnaa, E., Wong, M., Zapata, M., Behbakht, K., Bitler, B. G., Jeter, A., Fa, V. S., Ekroos, K., & McElhinny, A.
(2026). Multi-Omics Profiling in a Symptomatic Cohort Identifies Coordinated Biomarker Signatures in Ovarian Cancer Serum. Diagnostics, 16(14), 2143.
https://doi.org/10.3390/diagnostics16142143
